Reduced Injection Site Pain with Succinate Buffer-Based Adalimumab Biosimilar (ZRC-3197) Injection (SUFFER Study): An Observational Study
Saved in:
Main Authors: | Mihir Gharia, A Sudhakar |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2019-01-01
|
Series: | Indian Journal of Rheumatology |
Online Access: | http://www.indianjrheumatol.com/article.asp?issn=0973-3698;year=2019;volume=14;issue=2;spage=151;epage=152;aulast=Gharia |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Biosimilars in Focus: Evaluating Their Role Compared to Adalimumab in Clinical Practice
by: Dorota Waz, et al.
Published: (2025-01-01) -
The Effect of Intradermal Injection with Two Different Injection Techniques on Pain and Functional Status in Patients with Chronic Nonspecific Neck Pain
by: Sadiye MURAT
Published: (2024-12-01) -
Real-World Evidence of Clinical Outcomes of the Use of the Adalimumab Biosimilar SB5 in Rheumatic and Gastrointestinal Immune-Mediated Inflammatory Diseases: 12-Month Data from the PERFUSE Study
by: Bruno Fautrel, et al.
Published: (2024-10-01) -
Cull Cow Beef Quality Issues: Injection Sites and Abscesses
by: Amie Imler, et al.
Published: (2014-12-01) -
Cull Cow Beef Quality Issues: Injection Sites and Abscesses
by: Amie Imler, et al.
Published: (2014-12-01)